Affiliation:
1. Institute of Biomedical Engineering, Bogazici University, Istanbul, Turkey
Abstract
Background:
Accumulation of toxic strands of amyloid beta (AB), which cause neurofibrillary
tangles and, ultimately, cell death, is suspected to be the main culprit behind clinical symptoms of
Alzheimer’s disease. Although the mechanism of cell death due to AB accumulation is well known, the
intermediate phase between the start of accumulation and cell death is less known and investigated,
partially due to technical challenges in identifying partially affected cells.
Objective:
First, we aimed to establish an in vitro model that would show resilience against AB toxicity.
Then we used morphological, molecular and electrophysiological assays to investigate how the
characteristics of the surviving cells changed after AB toxicity.
Methods:
To investigate this phase, we used differentiation of SH-SY5Y neuroblastoma stem cells by
Retinoic Acid (RA) and Brain Derived Neurotrophic Factor (BDNF) to establish an in vitro model
which would be able to demonstrate various levels of resistance to AB toxicity. We utilized fluorescent
microscopy and whole cell patch clamp recordings to investigate behavior of the model.
Results:
We observed significantly higher morphological resilience against AB toxicity in cells which
were differentiated by both Retinoic Acid and Brain Derived Neurotrophic Factor compared to Retinoic
Acid only. However, the electrophysiological properties of the Retinoic Acid + Brain-Derived
Neurotrophic Factor differentiated cells were significantly altered after AB treatment.
Conclusion:
We established a transient survival model for AB toxicity and observed the effects of AB
on transmembrane currents of differentiated neurons.
Publisher
Bentham Science Publishers Ltd.
Subject
Neurology (clinical),Neurology